Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 2.58 USD -2.27%
Market Cap: 651.5m USD
Have any thoughts about
Maravai LifeSciences Holdings Inc?
Write Note

Wall Street
Price Targets

MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc

Wall Street analysts forecast MRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRVI is 8.92 USD with a low forecast of 3.03 USD and a high forecast of 13.86 USD.

Lowest
Price Target
3.03 USD
17% Upside
Average
Price Target
8.92 USD
246% Upside
Highest
Price Target
13.86 USD
437% Upside
Maravai LifeSciences Holdings Inc Competitors:
Price Targets
300404
Boji Medical Technology Co Ltd
18% Upside
ABSI
Absci Corp
184% Upside
688315
Novogene Co Ltd
17% Downside
SLV
Selvita SA
28% Upside
DIM
Sartorius Stedim Biotech SA
30% Upside
RGEN
Repligen Corp
34% Upside
300463
Maccura Biotechnology Co Ltd
5% Downside
688238
Obio Technology Shanghai Corp Ltd
17% Upside

Revenue
Forecast

Revenue Estimate
Maravai LifeSciences Holdings Inc

For the last 4 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 19%. The projected CAGR for the next 4 years is 4%.

19%
Past Growth
4%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRVI's stock price target?
Price Target
8.92 USD

According to Wall Street analysts, the average 1-year price target for MRVI is 8.92 USD with a low forecast of 3.03 USD and a high forecast of 13.86 USD.

What is Maravai LifeSciences Holdings Inc's Revenue forecast?
Projected CAGR
4%

For the last 4 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 19%. The projected CAGR for the next 4 years is 4%.

Back to Top